Aethlon Medical (AEMD) Scheduled to Post Earnings on Wednesday

Aethlon Medical (NASDAQ:AEMDGet Free Report) will be announcing its earnings results after the market closes on Wednesday, November 13th. Analysts expect the company to announce earnings of ($0.20) per share for the quarter.

Aethlon Medical (NASDAQ:AEMDGet Free Report) last announced its quarterly earnings results on Wednesday, August 14th. The medical equipment provider reported ($0.34) earnings per share for the quarter, beating the consensus estimate of ($0.44) by $0.10. During the same period in the previous year, the firm earned ($1.30) EPS.

Aethlon Medical Price Performance

Shares of NASDAQ AEMD opened at $0.38 on Thursday. The firm’s 50 day simple moving average is $0.39 and its 200-day simple moving average is $0.53. Aethlon Medical has a 12 month low of $0.24 and a 12 month high of $2.35. The stock has a market capitalization of $5.31 million, a price-to-earnings ratio of -0.10 and a beta of 1.74.

Analysts Set New Price Targets

Separately, StockNews.com initiated coverage on shares of Aethlon Medical in a research report on Thursday, October 31st. They issued a “sell” rating for the company.

Check Out Our Latest Research Report on Aethlon Medical

Aethlon Medical Company Profile

(Get Free Report)

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.

Featured Articles

Earnings History for Aethlon Medical (NASDAQ:AEMD)

Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.